Attaining sustainability in inflammatory bowel disease - Scorecard - MDSpire

Attaining sustainability in inflammatory bowel disease

  • By

  • Olga Maria Nardone

  • Beatriz Gros

  • Tommaso Lorenzo Parigi

  • Aimen Farooq

  • Lumir Kunovsky

  • Shaji Sebastian

  • November 19, 2025

  • 0 min

Share

Clinical Scorecard: Achieving Long-Term Sustainability in the Management of Inflammatory Bowel Disease

At a Glance

CategoryDetail
ConditionInflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis
Key MechanismsTreat-to-target strategies, biologics, small molecules, proactive monitoring, therapeutic drug monitoring, and integrated care pathways
Target PopulationPatients with IBD globally, including those in newly industrialized and low-resource countries
Care SettingMultidisciplinary healthcare systems with outpatient clinics, endoscopy units, and imaging services

Key Highlights

  • IBD prevalence is rising worldwide, increasing pressure on healthcare systems and resources.
  • Sustainable IBD care balances clinical effectiveness with affordability, equity, and environmental responsibility.
  • Climate change impacts IBD development and exacerbations; healthcare contributes significantly to carbon emissions.

Guideline-Based Recommendations

Diagnosis

  • Use validated biomarkers and imaging modalities (colonoscopy, CT, MRI, intestinal ultrasound) for proactive monitoring.
  • Adopt essential diagnostics that are context-appropriate and resource-efficient.

Management

  • Implement treat-to-target strategies aiming for steroid-free remission and prevention of cumulative bowel damage.
  • Optimize biologic and small-molecule therapies including therapeutic drug monitoring.
  • De-implement low-value practices and avoid clinical inertia in active disease.
  • Promote strong care coordination and support transitions between pediatric and adult services.
  • Integrate patient-reported outcomes into decision-making to enhance engagement and self-management.

Monitoring & Follow-up

  • Intensify monitoring demands with efficient use of biomarkers and imaging to balance clinical benefits and resource use.
  • Adopt telemedicine and green endoscopy practices to reduce environmental footprint.

Risks

  • Stringent targets may increase treatment burden, costs, and adverse effects.
  • Healthcare delivery contributes significantly to carbon emissions and environmental waste.
  • Limited access to advanced therapies and diagnostics may widen inequities in care quality and outcomes.

Patient & Prescribing Data

IBD patients across diverse healthcare settings including low-resource regions

Responsible adoption of biosimilars and rational sequencing of therapies can improve sustainability and access.

Clinical Best Practices

  • Balance clinical effectiveness with feasibility, affordability, and environmental sustainability.
  • Build scalable, context-appropriate care models that reduce unwarranted variation.
  • Coordinate multidisciplinary teams to optimize resource use and patient outcomes.
  • Incorporate environmental impact considerations into clinical decision-making.
  • Use telemedicine and reduce reliance on single-use materials to lower carbon footprint.

References

Original Source(s)

Related Content